Showing 1 – 3 of 3
Relevance | Newest | Oldest |
  • Omission of Axillary Dissection Following Nodal Downstaging With Neoadjuvant Chemotherapy

    Abstract Full Text
    online first
    JAMA Oncol. 2024; 10.1001/jamaoncol.2024.0578

    This cohort study examines oncological outcomes after sentinel lymph node biopsy with dual-tracer mapping or targeted axillary dissection.

  • Association of Axillary Dissection With Systemic Therapy in Patients With Clinically Node-Positive Breast Cancer

    Abstract Full Text
    open access has multimedia
    JAMA Surg. 2023; 158(10):1013-1021. 10.1001/jamasurg.2023.2840

    This cohort study investigates the association between the omission of axillary dissection and systemic therapy in patients with clinically node-positive breast cancer in the postneoadjuvant setting.

  • Improvement in Early Symptoms of Shock by Delayed Intestinal Protease Inhibition

    Abstract Full Text
    free access
    Arch Surg. 2004; 139(9):1008-1016. 10.1001/archsurg.139.9.1008